Vemurafenib improves muscle histopathology in a mouse model of LAMA2-related congenital muscular dystrophy

Vemurafenib improves muscle histopathology in a mouse model of LAMA2-related congenital muscular dystrophy

Bibliographic Details
Main Authors:	Ariany Oliveira-Santos, Marisela Dagda, Jennifer Wittmann, Robert Smalley, Dean J. Burkin
Format:	Article
Language:	English
Published:	The Company of Biologists 2023-06-01
Series:	Disease Models & Mechanisms
Subjects:	lama2-cmd congenital muscular dystrophy mdc1a laminin-α2 tgf-β mtor vemurafenib
Online Access:	http://dmm.biologists.org/content/16/6/dmm049916

Similar Items

Laminin and Integrin in LAMA2-Related Congenital Muscular Dystrophy: From Disease to Therapeutics
by: Pamela Barraza-Flores, et al.
Published: (2020-02-01)

Human laminin-111 and laminin-211 protein therapy prevents muscle disease progression in an immunodeficient mouse model of LAMA2-CMD
by: Pamela Barraza-Flores, et al.
Published: (2020-06-01)

Zebrafish Models of LAMA2-Related Congenital Muscular Dystrophy (MDC1A)
by: Lacramioara Fabian, et al.
Published: (2020-07-01)

Brain Dysfunction in LAMA2-Related Congenital Muscular Dystrophy: Lessons From Human Case Reports and Mouse Models
by: Andrea J. Arreguin, et al.
Published: (2020-07-01)

Limb girdle muscular dystrophy 23 caused by compound heterozygous mutations of LAMA2 gene
by: Yuqing Xu, et al.
Published: (2023-06-01)

Variable disease severity in Saudi Arabian and Sudanese families with c.3924 + 2 T > C mutation of <it>LAMA2</it>
by: Di Blasi Claudia, et al.
Published: (2011-12-01)

Congenital muscular dystrophy with inflammation: Diagnostic considerations
by: Kaumudi Konkay, et al.
Published: (2016-01-01)

Novel compound heterozygous mutations of LAMA2-limb–girdle muscular dystrophy: A case report and literature review
by: Duo-Zi Wang, et al.
Published: (2023-02-01)

Merosin-deficient congenital muscular dystrophy type 1a: detection of LAMA2 variants in Vietnamese patients
by: Van Khanh Tran, et al.
Published: (2023-06-01)

Natural history, outcome measures and trial readiness in LAMA2-related muscular dystrophy and SELENON-related myopathy in children and adults: protocol of the LAST STRONG study
by: Karlijn Bouman, et al.
Published: (2021-08-01)

Identification of Two Novel LAMA2 Mutations in a Chinese Patient with Congenital Muscular Dystrophy
by: Jing Zhou, et al.
Published: (2018-02-01)

Case report: Novel frameshift mutation in LAMA2 gene causing congenital muscular dystrophy type 1A
by: Natalia Diaz-Lombana, et al.
Published: (2023-06-01)

Impaired Regeneration in Dystrophic Muscle—New Target for Therapy
by: Nurit Yanay, et al.
Published: (2020-05-01)

Natural history and genetic study of LAMA2-related muscular dystrophy in a large Chinese cohort
by: Dandan Tan, et al.
Published: (2021-07-01)

LAMA2 Neuropathies: Human Findings and Pathomechanisms From Mouse Models
by: Stefano Carlo Previtali, et al.
Published: (2020-04-01)

A Mosaic Mutation in the LAMA2 Gene in a Case of Merosin-deficient Congenital Muscular Dystrophy
by: P. A. Chausova, et al.
Published: (2021-10-01)

Efficacy of Prednisolone in Generated Myotubes Derived From Fibroblasts of Duchenne Muscular Dystrophy Patients
by: Tsubasa Kameyama, et al.
Published: (2018-12-01)

Laminin α2 chain-deficiency is associated with microRNA deregulation in skeletal muscle and plasma
by: Johan eHolmberg, et al.
Published: (2014-07-01)

Case report: Adult-onset limb girdle muscular dystrophy in sibling pair due to novel homozygous LAMA2 missense variant
by: Matthew Katz, et al.
Published: (2023-01-01)

Early versus late diagnosis of LAMA2 congenital muscular dystrophy: a distinct consequence
by: Chien-Heng Lin, et al.
Published: (2024-01-01)

Congenital muscular dystrophy in a dog with a LAMA2 gene deletion
by: G. Diane Shelton, et al.
Published: (2022-01-01)

Whole Exome Sequencing as a Diagnostic Tool for Unidentified Muscular Dystrophy in a Vietnamese Family
by: Ngoc-Lan Nguyen, et al.
Published: (2020-09-01)

Novel mutation identification and copy number variant detection via exome sequencing in congenital muscular dystrophy
by: Edmund S. Cauley, et al.
Published: (2020-11-01)

Unique genotype-phenotype correlations within LAMA2-related limb girdle muscular dystrophy in Chinese patients
by: Xiuli Huang, et al.
Published: (2023-05-01)

A Missense Variant in LAMA3 Gene Causes Microcephaly and Epidermolysis Bullosa in a Pakistani Family
by: Zaib-Un-Nisa Mughal, et al.
Published: (2021-09-01)

RNA analysis of intronic variants in the LAMA2 gene detected by whole genome sequencing confirms a rare dual diagnosis of incontinentia pigmenti with limb‐girdle muscular dystrophy
by: Camerun Washington, et al.
Published: (2023-04-01)

Antioxidants Reduce Muscular Dystrophy in the <i>dy<sup>2J</sup>/dy<sup>2J</sup></i> Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy
by: Vahid M. Harandi, et al.
Published: (2020-03-01)

The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma
by: Hongmei Cui, et al.
Published: (2021-03-01)

A Rare Cause of Uveitis: Vemurafenib
by: Selçuk Sızmaz, et al.
Published: (2018-12-01)

Causative variants linked with limb girdle muscular dystrophy in an Iranian population: 6 novel variants
by: Hamidreza Mianesaz, et al.
Published: (2023-02-01)

Role of vemurafenib in the treatment of disseminated skin melanoma
by: L V Demidov, et al.
Published: (2013-06-01)

Delayed-onset vemurafenib-induced panniculitis
by: Stephen L. Vance, MD, MBA, et al.
Published: (2017-09-01)

Recessive LAMA5 Variants Associated With Partial Epilepsy and Spasms in Infancy
by: Sheng Luo, et al.
Published: (2022-05-01)

Identification of a novel LAMA2 c.2217G > A, p.(Trp739*) mutation in a Moroccan patient with congenital muscular dystrophy: a case report
by: Youssef El Kadiri, et al.
Published: (2021-04-01)

A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma
by: Meghan J. Mooradian, et al.
Published: (2018-05-01)

Congenital muscular dystrophy, cardiomyopathy, and peripheral neuropathy due to merosin deficiency: Peripheral nerve histology of cauda equina
by: Erika Hissong, M.D., et al.
Published: (2016-06-01)

SKIN TOXICITY OF TARGETED THERAPY: VEMURAFENIB, FIRST EXPERIENCES FROM MONTENEGRO
by: Todorović Vladimir, et al.
Published: (2015-07-01)

Sarcoid-like Granulomatous Intraocular Inflammation Caused by Vemurafenib Treatment for Metastatic Melanoma
by: Hilal Eser Öztürk, et al.
Published: (2020-01-01)

Spontaneous splenic rupture in patient with metastatic melanoma treated with vemurafenib
by: Castellani Elisa, et al.
Published: (2012-07-01)

LAMA2-Related Dystrophies: Clinical Phenotypes, Disease Biomarkers, and Clinical Trial Readiness
by: Anna Sarkozy, et al.
Published: (2020-08-01)